CENTER ID: | ChtrB.00944.a |
ORGANISM: | Chlamydia trachomatis D/UW-3/Cx |
ASSOCIATED DISEASE: | |
CURRENT STATUS: | purified |
COMMUNITY REQUEST: | True |
NIH RISK GROUP: | 2 |
SELECT AGENT: | False |
NIH PRIORITY pathogens category: |
non-BEI |
CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
---|---|---|---|---|---|
ChtrB.00944.a.AE1.GE44049 | full length | 1 | 242 | ||
ChtrB.00944.a.B1.GE42409 | full length | 1 | 242 |
CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
---|---|---|---|---|---|
ChtrB.00944.a.B1.PW38524 | full length | 1 | 242 |
METHOD | RESULTS |
---|---|
comparative modelling | Robetta_82011 |
RESOURCE | REFERENCE ID |
---|---|
PATRIC ID: | fig|272561.5.peg.228 |
UniProt: | O84215 |
HARVESTED ON: | 1/7/2021 |
SEQUENCED ON: | 1/8/2021 |
EXPECTED MW: | 28kDa |
OBSERVED MW: | 28kDa |
ANTIBIOTIC MARKER: | ampicillin |
COUNT OF EXPRESSION COLONIES: | Good (10-50) |
TOTAL EXPRESSION LEVEL: | Moderate Expression |
SOLUBLE EXPRESSION LEVEL | Moderate Expression |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
SEQUENCING RESULT: | |
PERCENT IDENTITY: | 100 |
PERCENT COVERAGE: | 100 |
HARVESTED ON: | 5/25/2018 |
SEQUENCED ON: | 5/31/2018 |
EXPECTED MW: | 28kDa |
OBSERVED MW: | 28kDa |
ANTIBIOTIC MARKER: | ampicillin |
COUNT OF EXPRESSION COLONIES: | Good (10-50) |
TOTAL EXPRESSION LEVEL: | High Expression |
SOLUBLE EXPRESSION LEVEL | High Expression |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
SEQUENCING RESULT: | |
PERCENT IDENTITY: | 99 |
PERCENT COVERAGE: | 100 |
PURIFICATION DATe: | 9/18/2018 |
CONCENTRATION: | 14.44mg/ml |
OBSERVED MW: | 28kDa |
EXPRESSION LEVEL: | Moderate Expression |
PROTEIN PURIFICATION BUFFER: | 25 mM HEPES pH 7, 500 mM NaCl, 5% Glycerol , 2 mM DTT, 0.025% Azide |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
VIAL COUNT (approx.): | 1 |
VIAL VOLUME: | 200µl |
PERCENT IDENTITY: | 99 |
PERCENT COVERAGE: | 100 |